Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP85810595Aexternal-prioritypatent/EP0189002B1/en
Application filed by Sandoz LtdfiledCriticalSandoz Ltd
Publication of MY100953ApublicationCriticalpatent/MY100953A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
USE OF A MONO OR DICYCLIC CARBOXYLIC OR HETEROCYCLIC CARBOXYLIC ACID ESTER OR AMIDE OF A ALCOHOL OR AMINE NITROGEN AS A RING ATOM IN FREE BASE FORM OR IN ACID ADDITION OR QUATERNARY AMMONIUM SALT FORM AS A 5-HT3 ANTAGONIST IN THE MANUFACTURE OF A MEDICAMENT SUITABLE FOR THE TREATMENT OF SCROTONIN INDUCED GASTROINTESTINAL DISTURBANCES.
MYPI87002000A1985-04-021987-09-28Treatment of gastrointestinal disorders
MY100953A
(en)